| | |
Three
Months Ended | |
| | |
September
30, | | |
June 30, | | |
September
30, | |
| | |
2024 | | |
2024 | | |
2023 | |
| | |
(unaudited) | | |
(unaudited) | | |
(unaudited) | |
| | |
(In thousands) | |
| Consolidated
GAAP loss from operations | |
$ | (13,515 | ) | |
$ | (4,632 | ) | |
$ | (6,513 | ) |
| Stock-based compensation | |
| 450 | | |
| 386 | | |
| 608 | |
| Depreciation and amortization expenses | |
| 340 | | |
| 326 | | |
| 426 | |
| Change in fair value of contingent consideration | |
| 7,140 | | |
| (1,031 | ) | |
| (435 | ) |
| Impairment losses | |
| — | | |
| — | | |
| 1,811 | |
| Consolidated
Non-GAAP loss from operations, as adjusted | |
$ | (5,585 | ) | |
$ | (4,951 | ) | |
$ | (4,103 | ) |
